Claris Ventures

Type

Venture Capital

Status

Active

Location

Turin, Italy

Total investments

11

Average round size

12M

Portfolio companies

6

Rounds per year

2.20

Lead investments

3

Follow on index

0.45

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareMedicalLife SciencePharmaceuticalTherapeuticsBiopharmaSimulationTranslation Service

Investor highlights

Industry focus
Biotech/Life Sciences
Stage focus
Series ASeedSeries B
Geo focus
Italy

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 100000000

Analytics

Total investments
11
Lead investments
3
Rounds per year
2.20
Follow on index
0.45
Investments by industry
  • Biotechnology (7)
  • Therapeutics (4)
  • Simulation (3)
  • Translation Service (3)
  • Life Science (2)
  • Show 4 more
Investments by region
  • Italy (8)
  • United Kingdom (3)
Peak activity year
2023

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
3
Group Appearance index
0.91

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
NeoPhore 01 Feb 2024 Biotechnology, Therapeutics, Simulation, Translation Service Early Stage Venture 13M England, Cambridge, United Kingdom
Resalis Therapeutics 05 Aug 2021 Seed 7M Piemonte, Torino, Italy

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.